Search results
New mRNA cancer vaccine triggers immune system to fight aggressive brain tumour
PA Media: Science via Yahoo News· 5 days agoAlthough it is too early to assess the clinical effects of the vaccine, the patients in the new...
News Highlights: Top Company News of the Day - Thursday at 9 AM ET
Morningstar· 5 days agoShares ticked up premarket as the company says it plans to return $9 billion to shareholders through dividends and stock buybacks in 2024. For the first time since before the onset of the < ...
Top Stock Movers Now: Moderna, Wayfair, Peloton Interactive, and More
Investopedia· 5 days agoThe Dow, S&P 500, and Nasdaq all rose. Moderna (MRNA) shares advanced after the vaccine maker...
Is Moderna Stock A Buy On Its Eye-Popping First-Quarter Sales Beat?
Investor's Business Daily· 4 days agoThey are also testing the cancer vaccine in patients with lung cancer. So, is Moderna stock now a...
Flu vs COVID: Stark Disparity in Vaccination and Deaths
Medscape· 5 days agoIn the first half of 2023, COVID-19 killed 42,670 people in the United States, while the flu killed...
Moderna, Inc. (NASDAQ:MRNA) Expected to Earn Q3 2025 Earnings of $1.30 Per Share
ETF DAILY NEWS· 23 hours agoWilliam Blair analyst M. Minter now anticipates that the company will earn $1.30 per share for the quarter, up from their prior estimate of $1.25. William Blair has a “Market Perform” rating ...
IMF chief Kristalina Georgieva calls U.S. debt load 'mind boggling'
LA Times via Yahoo Finance· 9 hours agoLightcap said that 92% of Fortune 500 companies are using the company's ChatGPT enterprise product....
The CDC Took Out 148 Pages of Essential Information
Mercola· 4 days agoPeople who receive a COVID-19 shot are at increased risk of myocarditis, or inflammation of the heart muscle,1 and pericarditis, which is inflammation of ...
Moderna Reports First Quarter 2024 Financial Results and Provides Business Updates
Digital Journal· 5 days agoReports first quarter revenues of $167 million, GAAP net loss of $1.2 billion and GAAP diluted EPS of $(3.07)Prepares for launches of RSV vaccine and Spikevax® 2024-2025 formula ...
Moderna Inc (MRNA) Q1 2024 Earnings: Significant Revenue Decline
Guru Focus· 5 days agoOn May 2, 2024, Moderna Inc (MRNA, Financial) released its 8-K filing, disclosing a challenging first quarter with total revenues of $167 million, a stark decline from $1.9 ...